Net acid extrusion from vascular smooth muscle (VSMCs) and endothelial cells (ECs) in the wall of resistance arteries is mediated by the Na<sup>+</sup>,HCO<sub>3</sub><sup>–</sup> cotransporter NBCn1 ( SLC4A7) and the Na<sup>+</sup>/H<sup>+</sup> exchanger NHE1 ( SLC9A1) and is essential for intracellular pH (pH<sub>i</sub>) control. Experimental evidence suggests that the pH<sub>i</sub> of VSMCs and ECs modulates both vasocontractile and vasodilatory functions in resistance arteries with implications for blood pressure regulation. The connection between disturbed pH<sub>i</sub> and altered cardiovascular function has been substantiated by a genome-wide association study showing a link between NBCn1 and human hypertension. On this basis, we here review the current evidence regarding (a) molecular mechanisms involved in pH<sub>i</sub> control in VSMCs and ECs of resistance arteries at rest and during contractions, (b) implications of disturbed pH<sub>i</sub> for resistance artery function, and (c) involvement of disturbed pH<sub>i</sub> in the pathogenesis of vascular disease. The current evidence clearly implies that pH<sub>i</sub> of VSMCs and ECs modulates vascular function and suggests that disturbed pH<sub>i</sub> either consequent to disturbed regulation or due to metabolic challenges needs to be taken into consideration as a mechanistic component of artery dysfunction and disturbed blood pressure regulation.